365 related articles for article (PubMed ID: 18407765)
1. Antibody-cytokine fusion proteins: applications in cancer therapy.
Ortiz-Sánchez E; Helguera G; Daniels TR; Penichet ML
Expert Opin Biol Ther; 2008 May; 8(5):609-32. PubMed ID: 18407765
[TBL] [Abstract][Full Text] [Related]
2. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
Gillies SD; Lan Y; Brunkhorst B; Wong WK; Li Y; Lo KM
Cancer Immunol Immunother; 2002 Oct; 51(8):449-60. PubMed ID: 12202906
[TBL] [Abstract][Full Text] [Related]
3. Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments.
Müller D
BioDrugs; 2014 Apr; 28(2):123-31. PubMed ID: 24018469
[TBL] [Abstract][Full Text] [Related]
4. Antibody-cytokine fusion proteins for the therapy of cancer.
Helguera G; Penichet ML
Methods Mol Med; 2005; 109():347-74. PubMed ID: 15585931
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
6. Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.
Young PA; Morrison SL; Timmerman JM
Semin Oncol; 2014 Oct; 41(5):623-36. PubMed ID: 25440607
[TBL] [Abstract][Full Text] [Related]
7. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
8. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer.
Dela Cruz JS; Huang TH; Penichet ML; Morrison SL
Clin Exp Med; 2004 Oct; 4(2):57-64. PubMed ID: 15672942
[TBL] [Abstract][Full Text] [Related]
9. Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity.
Shen S; Sckisel G; Sahoo A; Lalani A; Otter DD; Pearson J; DeVoss J; Cheng J; Casey SC; Case R; Yang M; Low R; Daris M; Fan B; Agrawal NJ; Ali K
Front Immunol; 2020; 11():832. PubMed ID: 32457754
[TBL] [Abstract][Full Text] [Related]
10. Antibody-cytokine fusion proteins for the therapy of cancer.
Penichet ML; Morrison SL
J Immunol Methods; 2001 Feb; 248(1-2):91-101. PubMed ID: 11223071
[TBL] [Abstract][Full Text] [Related]
11. [Immunotoxins and immunocytokines].
Contet A; Caussanel V; Beck A; Lowe P
Med Sci (Paris); 2019 Dec; 35(12):1054-1061. PubMed ID: 31903917
[TBL] [Abstract][Full Text] [Related]
12. Antibody-cytokine fusion proteins for improving efficacy and safety of cancer therapy.
Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Majidi J
Biomed Pharmacother; 2017 Nov; 95():731-742. PubMed ID: 28888210
[TBL] [Abstract][Full Text] [Related]
13. Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy.
Helguera G; Morrison SL; Penichet ML
Clin Immunol; 2002 Dec; 105(3):233-46. PubMed ID: 12498805
[No Abstract] [Full Text] [Related]
14. Antibody-cytokine fusion proteins.
Kontermann RE
Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
[TBL] [Abstract][Full Text] [Related]
15. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
Xiang J
Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
[TBL] [Abstract][Full Text] [Related]
16. Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation.
Murer P; Neri D
N Biotechnol; 2019 Sep; 52():42-53. PubMed ID: 30991144
[TBL] [Abstract][Full Text] [Related]
17. Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity.
Neri D
Cancer Immunol Res; 2019 Mar; 7(3):348-354. PubMed ID: 30824549
[TBL] [Abstract][Full Text] [Related]
18. Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy.
Hutmacher C; Neri D
Adv Drug Deliv Rev; 2019 Feb; 141():67-91. PubMed ID: 30201522
[TBL] [Abstract][Full Text] [Related]
19. Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity.
Fournier P; Aigner M; Schirrmacher V
Int J Oncol; 2011 Jun; 38(6):1719-29. PubMed ID: 21424118
[TBL] [Abstract][Full Text] [Related]
20. Immunocytokines for cancer treatment: past, present and future.
Neri D; Sondel PM
Curr Opin Immunol; 2016 Jun; 40():96-102. PubMed ID: 27060634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
